NASDAQ · ISRG
Intuitive Surgical, Inc.
$448.76+$4.58 (+1.03%)
Intuitive Surgical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 25.69% below the high.
Loading market information…
NASDAQ · CARL · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Carlsmed, Inc.’s quoted price sits in the upper half of its reported 52-week range, 8.47% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Carlsmed, Inc.’s next earnings report is currently expected on Nov 10, 2026, with estimated earnings per share of -$0.42. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Carlsmed, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:25 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 |
|---|
| Jun 26, 2025 |
| -$1.39-52.03% vs estimate |
| $10.19M-15.0% vs estimate |
THE ANALYST VIEW
3 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 2 contributors · Median target $18.50.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$448.76+$4.58 (+1.03%)
Intuitive Surgical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 25.69% below the high.
$11.37-$0.08 (-0.7%)
Alphatec Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.18% below the high.
$22.81+$0.90 (+4.11%)
Enovis Corporation’s quoted price sits in the lower half of its reported 52-week range, 29.62% below the high.
$22.41+$0.58 (+2.66%)
SI-BONE, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.31% below the high.
$31.52+$0.72 (+2.34%)
OrthoPediatrics Corp.’s quoted price sits in the upper half of its reported 52-week range, 3.37% below the high.
$2.38-$0.06 (-2.46%)
SS Innovations International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 73.05% below the high.
$10.24+$0.20 (+1.99%)
Orthofix Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.73% below the high.
$5.06+$0.23 (+4.76%)
Treace Medical Concepts, Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.91% below the high.
